Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
about
Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington diseaseOpinion: predictive testing for Huntington disease in childhood: challenges and implicationsA worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.Emotional and functional impact of DNA testing on patients with symptoms of Huntington's diseaseAdverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive TestingPredicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.Huntington's disease and the ethics of genetic prediction.Genetic testing for Huntington's disease.Linkage disequilibrium and modification of risk for Huntington disease.Discrimination as a consequence of genetic testing.Huntington disease and the abuse of geneticsTen years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction ConsortiumPredictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.Proceed with care: direct predictive testing for Huntington disease.Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation.Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.Disease gene identification: ethical considerations.New insight into neurodegeneration: the role of proteomics.Genetic counseling and testing for Huntington's disease: A historical review.When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada.Research samples from families with genetic diseases: a proposed code of conduct.Huntington's disease: update and review of neuropsychiatric aspects.Presymptomatic Diagnosis of Genetic Disorders: Is it worth the anxiety?Huntington's disease: predictive testing and the molecular genetics laboratory.Evidence of presymptomatic cognitive decline in Huntington's disease.History of genetic disease: the molecular genetics of Huntington disease - a history.Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).A grand challenge: providing benefits of clinical genetics to those in need.Homozygosity in Huntington's disease: new ethical dilemma caused by molecular diagnosis.Smartphone delivery of a hope intervention: Another way to flourish.Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group
P2860
Q24676732-EF3EFB08-56E6-4FAD-B341-82EE4F0BA101Q24677475-A124536A-8B99-4D4D-8E71-4E192E7BC7AFQ30446969-2CADFEE1-8A9F-42F8-A32E-617087D40E69Q33677075-281ADF0D-9F30-4BFB-8865-3100F7C12EC7Q33677909-A7F0B943-D547-410C-93F0-85A07FB5DD51Q33681277-18E04639-6BBC-4337-A5E4-B847DC7AAB5BQ34383165-BCFBAC9C-2C82-4D08-86AE-301573D8A4FCQ35168842-5B80FF09-0D0F-43F6-A250-9B8AB9C6A6E0Q35196462-94AA2CB5-E68E-4952-84F8-62F7155E8FB3Q35199339-C671AD2C-CB4E-4FF7-87D5-A3F73F95A925Q35199366-C6EE598F-D533-4B33-BC05-79F70DB0CE27Q35435335-3EF4EDF8-FEC7-466D-946C-0651279187C5Q35446354-2B449463-0CC2-483D-B002-8039A4D4FA90Q35821464-24C4E223-F37E-48DC-8B7C-663C424DA513Q35889419-05AA82A7-78CC-4B39-8AF7-EB8ED09FF951Q35889463-F52256DF-1DE6-4414-98FD-B84243CD6B01Q36900144-89FE91B3-30FD-4402-9264-3A6B40B37D6CQ37029649-9E6B6FD7-3B88-48E1-A598-340819F3C57BQ37107577-2F89E441-121B-4797-9C41-03C0ED6C27F2Q38170010-930656A3-46C9-4095-98CF-FA9F517117A6Q38833267-7F8F7939-7548-4E56-9F12-C066C61CA82EQ40047836-CF3C0B0C-67C7-4DAC-A58D-F36A218F2C80Q40382480-E154A2C5-2256-41BE-93F2-6FF3F6F9BD90Q40612866-DD54BD42-6855-48D1-8FEE-C9274E6A48A8Q41819106-A0627FFA-0209-4EA0-994E-1867D813746EQ45289748-71CAC3D3-6ACB-40D3-AB05-8ECB231DDC1FQ45291667-DF1341DF-B6D7-4545-9282-B59D1F58CAE8Q45298333-3632ADB6-A009-45AB-9164-5412E258B17AQ45298405-E546BD8E-B2B2-4C65-8318-6BE206720752Q45301537-E96BD692-4BBE-4D34-BE3B-D2D102B4498CQ45306474-831DE60D-B68E-448F-8A1A-7BF572DB5F2EQ55130933-F28056D5-A95B-4E3B-A478-F932172470D8Q58681325-7FA1BEA5-7167-4E0B-AB73-13012E6C0BBD
P2860
Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@en
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@nl
type
label
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@en
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@nl
prefLabel
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@en
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@nl
P2093
P1476
Presymptomatic diagnosis of de ...... ience in Huntington's disease.
@en
P2093
H H Kazazian
M H Abbott
N E Maestri
P R Slavney
S E Folstein
P304
P356
10.1001/JAMA.1989.03420210056016
P407
P577
1989-06-01T00:00:00Z